Here are five highlights:
1. Camber Spine Technologies launched the device in July 2016.
2. The ENZA Zero-Profile ALIF device is intended for use with autogenous bone graft in patients suffering from degenerative disc disease at one or two contiguous levels form L2 to S1.
3. Surgeons may utilize a laparoscopic or open anterior approach to implant the device.
4. The device is intended to boost patient safety by minimizing retraction during implantation via its integrated fixation.
5. Camber Spine Technologies plans to add to this platform using the patented ENZA Duo Presa Anchor Technology.
More articles on devices:
Integra LifeSciences saw $282.2M Q2 revenue — 6 observations
FDA clears CTL’s MATISSE Titanium ACIF Cage: 4 things to know
WishBone Medical reveals Exact Osteotomy System for pediatric orthopedic surgery cuts — 5 points
